Keywords
Zhengxu Xielian type cancer
Quality of life
Tumor markers
Submitted : 2025-03-20
Accepted : 2025-04-04
Published : 2025-04-19
Abstract
Objective: To explore the clinical efficacy of traditional Chinese medicine Fuzheng Quxie tea drinking package in the treatment of Zhengxu Xielian type cancer. Methods: In this study, 50 cases of Zhengxu Xielian type cancer admitted to our hospital from January 2020 to December 2021 were selected. They were divided into a control group (n = 25) and a treatment group (n = 25) according to the random number table method. The control group received conventional symptomatic treatment plus adjuvant therapy for cancer while the treatment group received traditional Chinese medicine Fuzheng Quxie tea drinking package plus conventional symptomatic treatment and adjuvant cancer therapy. Tumor marker indexes, quality of life scores, and fatigue scores before and after treatment were compared and analyzed between the two groups. Results: After treatment, the CEA, CA125, and NSE indexes in the treatment group were lower than those in the control group, and the differences were statistically significant (P < 0.05). After treatment, the quality of life scores of the treatment group were better, and the data between the two groups were statistically significant (P < 0.05). After treatment, the fatigue score of the observation group was significantly lower at 67.56 ± 4.69 compared to 110.59 ± 10.59 in the control group (t = 18.576, P < 0.05). Conclusion: The treatment of Zhengxu Xielian type cancer patients with traditional Chinese medicine Fuzheng Quxie tea drinking package can significantly reduce tumor marker indexes, improve patients’ quality of life, and reduce fatigue, which has clinical significance.
References
Wang X, Jiao Y, Liu Y, et al., 2024, Clinical Observation on the Adjuvant Treatment of Chemotherapy-Related Peripheral Neuropathy in Digestive Tract Tumors with Traditional Chinese Medicine Fumigation and Moxibustion. Journal of Practical Traditional Chinese Medicine, 40(11): 2304–2306.
Xu M, Jiang M, Zheng Y, 2024, Clinical Study on the Treatment of Intestinal Obstruction in Advanced Cancer with Enema of Yiqi Yangyin Formula. New Journal of Traditional Chinese Medicine, 56(11): 161–165.
Zhang Y, Wu S, Zheng L, 2022, Clinical Study on the Treatment of Intestinal Obstruction in Patients with Advanced Cancer by Traditional Chinese Medicine Enema Combined with Acupoint Application. Chinese Journal of Health Care Medicine, 24(1): 44–47.
Zheng X, 2002, Guiding Principles for Clinical Research of New Chinese Medicines (Trial). China Medical Science and Technology Press, Beijing: 361–367, 376–380, 385–392.
Li L, Wang H, Shen Y, 2002, Development and Performance Test of the Chinese Version of the SF-36 Health Survey Scale. Chinese Journal of Preventive Medicine, 2002(2): 38–42.
Xiong B, Liu T, Si Y, 2011, Application Concept of Fatigue Rating Scale in Special Service Recuperation. Chinese Journal of Convalescent Medicine, 20(1): 27.
Jiao H, Peng H, 2024, Discussion on the Treatment Principles and Methods of Primary Liver Cancer Based on the Liver’s Function of Dispersing and Discharging. Guangming Journal of Chinese Medicine, 39(7): 1322–1325.
Yuan M, Luo W, Donggui W, 2021, Experience in Treating Brain Metastasis of Breast Cancer Based on “Internal Wind Secretly Swirling”. Global Traditional Chinese Medicine, 14(4): 714–717.
Yang N, Wu L, Liu X, et al., 2019, Research Progress on the Regulation of Tumor Immune Microenvironment by Traditional Chinese Medicine. Journal of Liaoning University of Traditional Chinese Medicine, 21(8): 164–167.
Liu Y, Wu Y, Liu J, et al., 2021, Discussion on the Pathogenesis and Treatment of Tumors from the Transformation of Healthy Qi and Pathogenic Qi. Journal of Beijing University of Traditional Chinese Medicine, 44(2): 183–187.
Wu X, Deng H, 2022, Theory and Research Progress of Strengthening Healthy Qi to Treat Lung Cancer. Journal of Integrated Traditional Chinese and Western Medicine, 14(1): 45–47.
Pan Y, Yu Y, Wang X, et al., 2020, Tumor-Associated Macrophages in Tumor Immunity. Front Immunol, 11: 583084.
Zhu X, Zheng Y, Liu Z, et al., 2020, Network Pharmacology Analysis of the Synergistic Anticancer Mechanism of Major Flavonoids in Scutellaria Barbata. Traditional Chinese Drug Research and Clinical Pharmacology, 31(9): 1037–1044.